System Features Relevant to MT
- Autoimmune flare management is the defining skill for this category. During active flares (lupus, RA, scleroderma), tissues are inflamed, fragile, and pain-sensitive. Treatment should shift to gentle, supportive techniques — light Swedish, craniosacral, or simple holding. Between flares, more standard treatment depth may be appropriate.
- Inflammation types determine the approach. Local inflammation (acute injury response) benefits from avoiding the area and treating surrounding regions. Systemic inflammation (lupus flare, RA flare) requires global treatment modification — reduced pressure, shorter sessions, and parasympathetic-focused techniques.
- When to modify treatment depends on disease activity, not just diagnosis. A client with well-controlled RA in remission may tolerate normal-depth massage, while the same client during a flare needs a completely different approach. Always assess current status at intake.
- Connective tissue disorders like Ehlers-Danlos syndrome and scleroderma directly alter tissue properties. EDS causes hypermobility and fragile skin; scleroderma causes fibrosis and restricted ROM. Techniques must respect the tissue's actual capacity.
- Medication awareness is critical. Many autoimmune clients take immunosuppressants or corticosteroids, which increase infection risk and cause skin fragility. Some take biologics that may cause injection site reactions.
Condition Articles
Autoimmune Conditions
Connective Tissue and Genetic
Inflammatory Processes
Allergic and Immune Reactions
Infectious-Immune
Key Takeaways
- Always assess current disease activity at intake — treatment for autoimmune conditions is based on flare status, not diagnosis alone.
- During active autoimmune flares, shift to gentle, supportive techniques with reduced pressure and shorter duration.
- Local inflammation calls for avoiding the affected area; systemic inflammation calls for global treatment modification.
- Connective tissue disorders (EDS, scleroderma) permanently alter tissue properties and require ongoing technique adaptation.
- Immunosuppressant medications increase infection risk and cause tissue fragility — factor medication status into every treatment plan.